FDA Data Integrity Guidance: Applying Risk-Based Approaches Across Systems

digi — Sat, 15 Nov 2025 08:11:47 +0000

FDA Data Integrity Guidance: Applying Risk-Based Approaches Across Systems Implementing FDA Data Integrity Guidance Through Risk-Based System Prioritisation Data integrity remains a cornerstone of pharmaceutical quality systems globally, underpinning patient safety, product efficacy, and regulatory compliance. The FDA data integrity guidance issued in recent years emphasizes a risk-based approach to managing data through manufacturing, laboratory,...

risk-based approach – Pharma GMP

FDA Data Integrity Guidance: Applying Risk-Based Approaches Across Systems